Optimal management of superior sulcus tumors remains challenging. This SWOG protocol was a feasibility study of the utility of consolidation therapy with docetaxel in addition to cisplatin-etoposide, 45Gy, and possible resection. Of 46 registered pts, 86% completed induction therapy, 66% underwent resection, and 45% completed consolidation therapy
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Lung - Cancer
August 5, 2014
July 29, 2014
Records of nearly 24,000 Australian patients with NSCLC were evaluated to determine the relationship between distance to the nearest speciality hospital (NASH) and survival. Increasing distance from a NASH was associated with decreasing likelihood of admission to a NASH and decreasing likelihood of lung cancer resection, resulting in an increasing h
July 28, 2014
Participants in the Lung Cancer Screening Trial were evaluated for success in smoking cessation linked to findings in their screening CTs. The odds ratios for continued smoking decreased with increasingly worrisome abnormalities on CTs: 0.81 for a major abnormality not suspicious for cancer, 0.79 for an abnormality suspicious for cancer but stable,
July 26, 2014
Outcomes of lung adenocarcinoma classified according to the new IASLC/ATS/ERS system were evaluated in this retrospective single-institution study involving 573 pts who underwent surgical treatment. Histologic patterns were associated with sex and tumor TNM factors. Recurrence was higher in micropapillary and solid-predominant cancers. These subty
July 26, 2014
This article presents guidelines on the diagnosis and management of advanced stage lung cancer developed by the ESMO in 2013.
July 26, 2014
This article summarizes consensus guidelines for the diagnosis and management of early stage lung cancer developed by ESMO in 2013.
July 12, 2014
This editorial, authored by a number of presidents/leaders of prominent medical societies, laments a recent position paper of the ESMO espousing medical oncologists as the natural team leaders of multidisciplinary oncologic care. It cautions other cancer specialists not to abandon their roles as advocates for their cancer patients.
July 8, 2014
Stephanie Worrel discusses the use of lobectomy in lung cancer patients over 75 years old, and the impact robotic lobectomy has on outcomes.
July 1, 2014
This single institution retrospective study compared outcomes for lobectomy and segmentectomy using propensity score matching. For 312 pts in each group, there was no difference in logoregional or overall recurrence rates. Operative mortality rates were similar for segmentectomy and lobectomy (1.2% vs 2.5%). 5-year surival rates were also similar
July 1, 2014
This randomized trial of high risk patients with small clinial stage I cancers randomized pts to sublobar resection with or without adjuvant brachytherapy. The median follow-up for 222 pts was 4.4 years. 3 year survival was identical (71%) between the groups. There was no difference in time to local recurrence. Brachytherapy did not significantly